Experiment 443522

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

SHIKONIN

Details

PropertyValue
Pharmacology
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Administration routeEXTERNAL
OrganismEmpty organism
CitationSETO,Y: MOTOYOSHI,S: NAKAMURA,H: IMUTA,JI: ISHITOKU,T: ISAYAMA,S:. (1992). EFFECT OF SHIKONIN AND ITS DERIVATIVES, PENTAACETYLATED SHIKONIN (MDS-004) ON GRANULOMA FORMATION AND DELAYED-TYPE ALLERGY IN EXPERIMENTAL ANIMALS.. 112(4)
Amount utilized
Compound isolated
DiseaseVS.DNFB-INDUCED DELAYED-TYPE HYPERSENSITIVITY. SWELLING WAS INHIBITED 27.8%.
Dose amount1.0 MG
Number6
Qualitative resultACTIVE
AnimalMOUSE
Per unitEAR
Dose expressionDOSE